Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab

Detalles Bibliográficos
Autores principales: Saburi, Masuho, Sakata, Masanori, Kodama, Yousuke, Uraisami, Keiichi, Takata, Hiroyuki, Miyazaki, Yasuhiko, Wada, Junpei, Urabe, Shogo, Ohtsuka, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628823/
https://www.ncbi.nlm.nih.gov/pubmed/37518271
http://dx.doi.org/10.3960/jslrt.23017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628823/
https://www.ncbi.nlm.nih.gov/pubmed/37518271
http://dx.doi.org/10.3960/jslrt.23017

Ejemplares similares